Review



tissue array blocks bl2081  (Biomax Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Biomax Inc tissue array blocks bl2081
    A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays <t>BL2081</t> and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.
    Tissue Array Blocks Bl2081, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+array+blocks+bl2081/tissue+array+blocks+bl+806/pmc05628127-142-2-9
    Average 90 stars, based on 1 article reviews
    tissue array blocks bl2081 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer"

    Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer

    Journal: Molecular cancer therapeutics

    doi: 10.1158/1535-7163.MCT-16-0924

    A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.
    Figure Legend Snippet: A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

    Techniques Used: Staining, Expressing

    Related Articles

    other:

    Article Title: Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
    Article Snippet: Figure 1 EGFR and HER2 expression in bladder cancer. ( A ) TCGA dataset was used to show increased expression of EGFR and HER2 in bladder cancer. (i) EGFR is significantly elevated in bladder cancer compared to normal urothelium ( P < 0.01; ANOVA), specifically in ‘basal’ subtype classes 3 and 4. (ii) HER2 is significantly elevated in bladder cancer compared to the normal urothelium ( P < 0.01; ANOVA), specifically in ‘luminal’ subtype classes 1 and 2. ( B ) Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for the presence of EGFR and HER2 expression.

    Article Title: Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer
    Article Snippet: Commercially available tissue array blocks BL2081 and BL 806 (Biomax, Rockville, MD) were similarly stained with anti-EGFR antibody to detect the expression of EGFR in bladder tumors of on June 18, 2017.

    Article Title: Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
    Article Snippet: Two commercially available TMAs were purchased from Biomax (Rockville, MD): BL2081 and BL806.

    Staining:

    Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer
    Article Snippet: .. Commercially available tissue array blocks BL2081 and BL 806 (Biomax, Rockville, MD) were similarly stained with anti-EGFR antibody to detect the expression of EGFR in bladder tumors of various stages, grades, and histologies as well as adjacent normal bladder tissues. ..

    Article Title: High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging
    Article Snippet: .. The bladder cancer tissue array (#BL2081a) was purchased from Biomax (Rockville, MD, USA) and was used for immunohistochemical (IHC) staining to evaluate the expression of TJP1 protein. ..

    Expressing:

    Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer
    Article Snippet: .. Commercially available tissue array blocks BL2081 and BL 806 (Biomax, Rockville, MD) were similarly stained with anti-EGFR antibody to detect the expression of EGFR in bladder tumors of various stages, grades, and histologies as well as adjacent normal bladder tissues. ..

    Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer
    Article Snippet: .. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). ..

    Article Title: High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging
    Article Snippet: .. The bladder cancer tissue array (#BL2081a) was purchased from Biomax (Rockville, MD, USA) and was used for immunohistochemical (IHC) staining to evaluate the expression of TJP1 protein. ..

    Immunohistochemical staining:

    Article Title: High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging
    Article Snippet: .. The bladder cancer tissue array (#BL2081a) was purchased from Biomax (Rockville, MD, USA) and was used for immunohistochemical (IHC) staining to evaluate the expression of TJP1 protein. ..

    Immunohistochemistry:

    Article Title: High expression of tight junction protein 1 as a predictive biomarker for bladder cancer grade and staging
    Article Snippet: .. The bladder cancer tissue array (#BL2081a) was purchased from Biomax (Rockville, MD, USA) and was used for immunohistochemical (IHC) staining to evaluate the expression of TJP1 protein. ..

    Microarray:

    Article Title: Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer
    Article Snippet: .. BUC tissue microarray (BL2081) was purchased from Biomax, including 192 bladder tumor samples and 16 normal adjacent tissue samples. ..



    Similar Products

    tissue array blocks bl2081  (Biomax Inc)
    90
    Biomax Inc tissue array blocks bl2081
    A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays <t>BL2081</t> and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.
    Tissue Array Blocks Bl2081, supplied by Biomax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+array+blocks+bl2081/tissue+array+blocks+bl+806/pmc05628127-142-2-9
    Average 90 stars, based on 1 article reviews
    tissue array blocks bl2081 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

    Journal: Molecular cancer therapeutics

    Article Title: Epidermal Growth Factor Receptor (EGFR) Targeted Photoimmunotherapy (PIT) for the Treatment of EGFR expressing Bladder Cancer

    doi: 10.1158/1535-7163.MCT-16-0924

    Figure Lengend Snippet: A. Staining intensity of bladder cancer tissue cores by T stage. Tissue microarrays BL2081 and BL806 (Biomax) were analyzed for presence of EGFR expression using anti-EGFR antibody (CST No. 4267). Each sample was graded for staining as follows: 0=<10% of cells positive (black); 1=10–24% (maroon); 2=25–49 % (red); 3=50–74% (firebrick); 4=75–100% (pink). There is no relationship between EGFR staining and T stage.

    Article Snippet: Commercially available tissue array blocks BL2081 and BL 806 (Biomax, Rockville, MD) were similarly stained with anti-EGFR antibody to detect the expression of EGFR in bladder tumors of various stages, grades, and histologies as well as adjacent normal bladder tissues.

    Techniques: Staining, Expressing